The goal of the Scourge project was to search for risk genomic biomarkers with predisposition to suffer a severe infection due to SARS-CoV-2, causing agent of COVID-19, as well as the response of the planned drugs for its treatment with the purpose of having an immediate impact in the clinical handling and therapeutic decisions of infections due to SARS-CoV-2.
Acronym
Scourge
Description
This project got all the Spanish autonomous communities involved as well as some countries in Latin America. Recruiting patients in close collaboration with the initiative STOP-Coronavirus.
Developers of the project
Gene Therapy and Pharmacogenomics (TerGenOMIC)
Keywords
covid-19
Principal investigators:
- Herrero Cervera, Maria Jose
- PDI-Ajudant Doctor/A
- Sendra Gisbert, Luis
- PDI-Ajudant Doctor/A
- Aliño Pellicer, Salvador Francisc
- PDI-Emerit/a Universitat
Start date
2020
January
End date
2020
December
Project type
- AGE - Health Research Projects
